Clinical Patterns of Rocuronium and Cisatracurium Use in Acute Respiratory Distress Syndrome: A Retrospective Cohort Study
Open Access
Abstract
Background: Neuromuscular blockade (NMB) is frequently used in moderate-to-severe acute respiratory distress syndrome (ARDS) to optimize ventilatory synchrony and minimize ventilator-induced lung injury. However, comparative real-world data on different NMB strategies remain limited. Objective: To describe patterns of neuromuscular blockade use in ARDS and describe clinical outcomes across four NMB strategies: intermittent rocuronium, continuous cisatracurium, escalation from rocuronium to cisatracurium, and de-escalation from cisatracurium to rocuronium. Methods: A retrospective chart review was conducted in an 18-bed tertiary ICU at Hôpital Montfort (Ottawa, Canada) between November 2021 and March 2025. Adult ARDS patients who received NMB for >24 h were included. Continuous variables (age, ventilation time, ICU stay) were summarized as means ± SD and median [IQR]; categorical variables (sex, ARDS etiology, mortality) as counts and percentages. Inferential testing was limited to baseline characteristics; clinical outcomes were summarized descriptively. Results: Fifty-one patients met inclusion criteria: rocuronium (n = 20), cisatracurium (n = 14), rocuronium→cisatracurium (n = 8), and cisatracurium→rocuronium (n = 9). Mean ventilation durations were 280, 195, 272, and 262 h, respectively; corresponding ICU stays were 245, 237, 380, and 299 h. Mortality ranged from 25% to 56%. Escalation from rocuronium to cisatracurium typically reflected persistent dyssynchrony or worsening oxygenation, whereas de-escalation occurred in improving patients with residual ventilatory drive. Variability in corticosteroid use, adjunctive proning, and epoprostenol were potential confounders. Conclusions: Distinct NMB use patterns in ARDS reflect bedside clinical judgment rather than predefined thresholds. Patient trajectory and dyssynchrony severity appear to drive NMBA escalation decisions more than oxygenation indices alone. These findings highlight the need for prospective studies defining standardized criteria for NMB initiation, escalation, and weaning in ARDS.Keywords
Funding Information
- Association Médicale Universitaire Montfort (AMUM), Department of Medicine (2025-A15)
This publication has 15 references indexed in Scilit:
- An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2024
- ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategiesIntensive Care Medicine, 2023
- Patient–ventilator dyssynchrony in the intensive care unit: A practical approach to diagnosis and managementAnaesthesia and Intensive Care, 2021
- Diagnostic value of cardiopulmonary ultrasound in elderly patients with acute respiratory distress syndromeBMC Pulmonary Medicine, 2018
- Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill PatientCritical Care Medicine, 2016
- Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 CountriesJAMA, 2016
- Neuromuscular Blockers in Early Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2010
- Paralysis in the critically ill: Intermittent bolus pancuronium compared with continuous infusionCritical Care Medicine, 1999
- A Pharmacoeconomic Analysis of Neuromuscular Blocking Agents in the Operating RoomPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1996
- Critical illness polyneuropathyCritical Care Medicine, 1996